Production Facilities

MYM through its various joint ventures is currently building three large-scale production facilities in both Canada and Australia. Upon completion of these three projects, the total amount of greenhouse growing space is expected to exceed 2.7 million square feet.

The Weedon Project

Weedon, Quebec

The Weedon Project - The 1.5 million sf greenhouse project has been approved by the City of Weedon. A license application has been submitted to Health Canada. MYM has purchased through its partially owned subsidiaries 329 acres of land to build on. This project will include a cannabis museum and a cannabis university for industry training.

Learn More

Production Size (SQ FT)

2018 | 30,000
2019 | 30,000
2020 | 1,500,000

The Laval Project

Laval, Quebec

The Laval Project - The facility has been completed and is awaiting licensing from Health Canada. The facility is currently 10,000 sf and will be expanded to 37,000 sf. Once the appropriate licenses are received from Health Canada, it will enable MYM to produce and market its branded THC and CBD medical products across Canada.

Learn More

Production Size (SQ FT)

2018 | 10,000
2019 | 37,000
2020 | 37,000

The Northern Rivers Project

Casino, New South Wales, Australia

The Northern Rivers Project owned by Solaris Nutraceuticals – a 1.2 million sf greenhouse project which, upon completion, is expected to be the largest cannabis greenhouse in Australia. Subject to receiving the appropriate licenses, the first crop is expected to be planted in the second quarter of 2019. Solaris Nutraceuticals received a AUD $2,500,000 grant from Federal Department of Innovation, Industry & Science for this project. MYM owns 35% of Solaris Nutraceuticals -

Production Size (SQ FT)

2018 | TBD
2019 | TBD
2020 | 1,200,000

MJT Manufacturing

Toronto, Ontario

MJT Manufacturing Project – the 5,000 SF production facility located in Toronto, Ontario is a GMP certified, state of the art extraction lab and production facility dedicated to industrial hemp processing (CBD). This high capacity production space is able to produce large volumes with a high level of consistency. The facility is capable of producing a full range of CBD extracts and isolates. The MJT production facility is focussed on product development for MYM owned brand.

Press Releases

10/18/17 - MYM Enters Partnership to Build One Million Square Foot Cannabis Production Facility in Australia


10/10/17 - MYM Announces Consulting Agreement with Master Grower


09/28/17 - MYM Announces Partnership with Quebec Public Relations Experts – Nadeau Bellavance


09/26/17 - MYM Announces Non-Brokered Financing


09/26/17 - MYM Finalizes Lease Agreement on Building for Phase B of Laval, QC Project


09/19/17 - MYM Enters Into Consulting Agreement with Leading Cannabis Industry Legal Experts – International Cannabis Consultants Co.


09/06/17 - MYM Enters Into Asset Purchase and Consulting Agreement with “Mary Jane’s Touch”


08/21/17 - MYM Retains Salman Capital Inc. as Financial Advisor to the Company


08/16/17 - MYM Receives Permit Approval to Complete Construction on Laval, QC Project


08/16/17 - MYM Receives Permit Approval to Begin Construction on Laval, QC Project


08/11/17 - MYM Announces “Open House” for Weedon, QC Project August 17, 2017


08/03/17 - MYM Enters into Agreement with Engineering Firm to Conduct Environmental Tests for Weedon, QC Project


07/31/17 - MYM Completes Architectural Layout and Finalizes Security Plans for Phase One ACMPR Greenhouses at the Weedon, QC project


07/27/17 - New Health Canada Regulations Allow for Substantial Increase in MYM Vault Size


07/17/17 - MYM Welcomes Nicolas Elbaze to the Sublime Team


06/29/17 - MYM and GGS Structures Working Together on Weedon Greenhouse Project and Quality Assurance Person Joins Team


06/26/17 - MYM Interviewed by CBC National News Regarding Weedon Project


06/23/17 - MYM Acquires CBD Brand “Joshua Tree”


06/20/17 - MYM to Build 1.5 Million Square Foot Cannabis Greenhouse Facility in Weedon, QC


06/19/17 - MYM Announces Terry Brown as New Investor Relations Representative


06/16/17 - MYM Receives DTC Approval Allowing US Investors to Trade Shares Under the Symbol MYMMF


06/07/17 - Compensation for New Director and Executive Chairman


06/02/17 - MYM Appoints New Director and Insiders Buy Shares


06/01/17 - MYM Announces Close of Non-Brokered Financing


05/10/17 - Acquisition Update: HempMed Sales Exceed Expectations


05/04/17 - MYM Announces Non-Brokered Private Placement


04/28/17 - MYM Announces Rob Gietl as New CEO


04/11/17 - MYM Closes Acquisition of Leading Hemp CBD Brand “HempMed”


04/05/17 - MYM to Develop the Cannabis “Gold Standard” for Product Testing Process and Technology in Canada


03/10/17 - MYM to Acquire Leading Hemp CBD Brand “HempMed”


02/22/17 - MYM Closes Acquisition of Majority Interest in Inspection-Stage Licensed Producer Application


02/09/17 - MYM Announces Closing of Non-Brokered Financing


02/01/17 - MYM Announces Acquisition of Majority Interest in Stage -4 Licensed Producer Application

Management Team

Mr. Erick Factor has been appointed to the Company’s Board of Directors and will also serve as Executive Chairman. Mr. Factor is a well-known expert in the cannabis industry and has 20 years of experience in cultivating medical marijuana and manufacturing cannabis by-products, and has provided medical marijuana to thousands of patients over the past two decades. Mr. Factor is also the founder of the “Westcoast Medicann” dispensary, one of just a  handful of dispensaries in Vancouver to be licensed under the City of Vancouver’s stringent bylaws. He has extensive experience working with Health Canada, from whom he has obtained MMAR and MMPR licenses for hundreds of patients, and has managed and operated grow facilities to produce for those patients. Mr. Factor has also gained invaluable experience over the past three years in ACMPR licensing regulations and applications.

Mr. Gietl was most recently the Director of Business Development at NRI Global Inc. where he headed up multi-million dollar industrial acquisitions, environmental remediation and global sales of reusable assets and commodities. His skills in negotiations and plan development enabled him to leverage partnerships to accelerate expansion and facilitate synergy in execution. Mr. Gietl is well known for his ability to exponentially grow businesses including the west coast franchise expansion of Dominos Pizza, where he Consistently grew the annual business to achieve 300+% increases year over year. Mr. Gietl is a seasoned Business Development and Operations executive with a diverse track record of leading change across all areas of concept creation, brand re-positioning, market penetration, fiscal accountability and efficient execution of business plans. He has grown business effectiveness in an array of sectors and circumstances throughout Canada, consistently aligned with stakeholders goals and values.

Craig Lennox is a proven leader with an extensive background in financial management and operations. Mr. Lennox was most recently CFO at Clearly, a leading online optical retailer. He is a Chartered Professional Accountant and holds a Bachelor of Commerce degree from Queen’s University. He worked at Ernst & Young LLP in Toronto and Vancouver serving both public and private companies. Mr. Lennox spent over 5 years at The Jim Pattison Group Corporate Office in various senior financial roles. Mr. Lennox joined Clearly (Coastal Contacts Inc. – TSX listed) in 2012 as Vice-President of Finance where he was involved in building the business, listing the Company on the Nasdaq and in the ultimate sale of the company in April 2014 to Essilor for $430m. Mr. Lennox became Chief Financial Officer at Clearly in April 2014 and held that role until joining MYM.

Charith Adkar completed his PhD in Plant Biology and Crop Production from the University of Milano, Italy with the specialization in Molecular Plant Pathology. He has done his postdoctoral studies at Hirosaki University, Japan and Université de Sherbrooke, Canada. His areas of expertise include: Plant Science, Biotechnology, Microbiology, Molecular host-pathogen interactions and Bioinformatics. His career highlights include the development of molecular diagnostic kits for the detection of pathogens, studies on molecular basis of pathogenesis of non-coding RNAs. His work has featured in more than 45 scientific publications, a book chapter and a filed patent as a co-inventor. He has given several invited talks at national and international scientific meetings as well as at universities. He is a member of several international and national professional societies and serves as a scientific reviewer in high-impact biological science journals. He has received several prestigious fellowships such as Japan Society for promotion of Sciences (JSPS) Postdoctoral Fellowships for Foreign Researchers, Fonds québécois de la recherche sur la nature et les technologies (FQRNT), Quebec, Canada. He also received the best research article award from the Phytopathological Society of Japan and Journal of General plant pathology for the research article for the year 2015.

Ian Ramage grew up in British Columbia and holds a Computer Engineering degree from Simon Fraser University and J.D. and LL.M. degrees from the  University of British Columbia. He practiced law in the Bay Area for eight years for a variety of biotech and high-tech clients, returning to Vancouver in  2009 to continue to build his corporate and securities practice. Most recently, Ian was counsel for a national chain of marijuana dispensaries and has advised several others on marijuana regulations and corporate matters.

Stock Info